Target intelligence / Profile preview

ATP1B3 antisense RNA 1 (ATP1B3-AS1)

Target: ATP1B3-AS1
Molecular classification: Other (long non-coding RNA), long non-coding RNA

Overview

ATP1B3 antisense RNA 1 (ATP1B3-AS1) is a long non-coding RNA gene. It is designated based on its genomic overlap (antisense orientation) with the ATP1B3 gene. Currently, little is known about its specific biological function, role in disease, or utility as a biomarker, and it is not considered a therapeutic target in drug discovery or clinical development contexts. It is not a classical protein therapeutic target such as a receptor, enzyme, transporter, or ion channel. ATP1B3-AS1 should not be confused with the protein-coding gene ATPase Na+/K+ transporting subunit beta 3 (ATP1B3). There is no evidence that ATP1B3-AS1 codes for a receptor, enzyme, or transporter, nor that it is directly targeted by any pharmacological agents.

Other names: ATP1B3-AS1

Mechanism of action

Not applicable.

Biological functions

Currently, there are no well-established, specific biological functions for ATP1B3-AS1 in major biological databases.It is annotated as a non-coding RNA gene.

Disease associations

Not clearly established. There is no confirmed implication as a direct disease gene or biomarker according to available databases.

Beyond the preview

Go deeper on ATP1B3 antisense RNA 1 (ATP1B3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP1B3 antisense RNA 1 (ATP1B3-AS1).

Explore the full profile